Cover Image

OP 6.3 - 00150 Delivery and long-term expression of CCR5-blocking monoclonal antibody Leronlimab with AAV for ART-free remission from SHIV viremia

Saved in:

Bibliographic Details
Main Authors:	G. Webb (Author), H. Wu (Author), C. Waytashek (Author), C. Boyle (Author), J. Smedley (Author), J. Zikos (Author), D. Magnani (Author), S. Fuchs (Author), R. Desrosiers (Author), J. Sacha (Author)
Format:	Book
Published:	Elsevier, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FcRn-enhancing mutations lead to increased and prolonged levels of the HIV CCR5-blocking monoclonal antibody leronlimab in the fetuses and newborns of pregnant rhesus macaques
by: Joanna Zikos, et al.
Published: (2024)

OP 2.1 CCR5 in HIV Prevention and Cure
by: Helen L. Wu, et al.
Published: (2022)

OP 6.6 - 00134 Viral Suppression in SHIV-infected Rhesus Macaques following AAVmediated Delivery of Closer-to-germline Monoclonal Antibodies
by: J. Martinez-Navio, et al.
Published: (2022)

OP 6.8 - 00102 In vivo evolution of env in SHIV-AD8-infected rhesus macaques after AAV-eCD4-Ig therapy
by: D. O'Hagan, et al.
Published: (2022)

The human IL-15 superagonist N803 does not reverse latency in ART-suppressed, SHIV-infected macaques
by: G. Webb, et al.
Published: (2019)

OP 1.3 - 00017 The fraction of cells with unspliced HIV RNA is not associated with plasma viremia
by: A. Capoferri, et al.
Published: (2022)

How long is long-term? Delivery of anti-HIV antibodies using AAV vector
by: J. Martinez-Navio, et al.
Published: (2019)

OA3-2 CCR5 gene edited cells traffic to viral reservoir tissues and undergo SHIV-dependent positive selection in nonhuman primates
by: C.W. Peterson, et al.
Published: (2016)

OP 6.5 - 00164 Nanobody-engineered AAV vectors for CD4-targeted gene therapy
by: U. Lange, et al.
Published: (2022)

OP 6.1 It's a mountain not a hill: Progress made in realizing AAV-delivered inhibitors for an HIV cure
by: Matthew R. Gardner
Published: (2022)

Maternal HBeAg positivity and viremia associated with umbilical cord blood hepatitis B viremia
by: Le Ye Lee, et al.
Published: (2019)

PP 6.3 - 00178 Targeting the human and macaque CCR5 genes using the CRISPR-SaCas9 gene-editing platform
by: M. Caocci, et al.
Published: (2022)

HIV viremia is the product of a small fraction of infected cells
by: E. Anderson, et al.
Published: (2017)

Sustained SHIV reactivation by N-803 in ART-treated CD8-depleted macaques
by: J.B. McBrien, et al.
Published: (2019)

OP 6.7 - 00044 Long-term ART-free SIV Remission Following Allogeneic Hematopoietic Cell Transplantation in Mauritian Cynomolgus Macaques
by: H. Wu, et al.
Published: (2022)

OP 3.2 - 00056 Clonally expanded HIV-1 proviruses with 5'-Leader defects can give rise to nonsuppressible residual viremia and complicate ART management
by: F. Wu, et al.
Published: (2022)

Conditions for post-rebound SHIV control in autologous hematopoietic-stem cell transplantation
by: F. Cardozo, et al.
Published: (2019)

Rapamycin immune tolerization enables gene transfer following subcutaneous delivery of AAV6 but not CD4-retargeted AAV6 vectors in AAV-seropositive rhesus macaques
by: K. Jerome, et al.
Published: (2019)

Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes
by: Dzerassa Gurtsieva, et al.
Published: (2024)

An AAV-Based NF-κB-Targeting Gene Therapy (rAAV-DMP-miR533) to Inflammatory Diseases
by: Luo T, et al.
Published: (2022)

CCR9 Antagonists in the Treatment of Ulcerative Colitis
by: Pirow Bekker, et al.
Published: (2015)

Perspectieven op milieurisico's
by: Bouma, J.
Published: (2002)

PP 2.17 - 00187 Myeloid-derived extracellular vesicle production is upregulated with SHIV.D infection
by: R. Podgorski, et al.
Published: (2022)

Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes in lymph nodes and reduces SHIV RNA
by: G. Pavlakis, et al.
Published: (2017)

OP 2.5 - 00048 Targeting the SIV reservoir with Alemtuzumab
by: B. Varco-Merth, et al.
Published: (2022)

Novel SHIVs encoding transmitted/founder envs for latency and cure research
by: K. Bar, et al.
Published: (2017)

Novel SHIVs encoding transmitted/founder Envs for latency and cure research
by: A. Bauer, et al.
Published: (2019)

The transcriptional program governed by RORγt favors HIV-1 replication in CCR4+CCR6+ Th17 cells
by: V.S. Wacleche, et al.
Published: (2015)

Aortic Arch Thrombosis Associated with Fetal Cytomegalovirus Viremia
by: Elif Gul Yapar Eyi, et al.
Published: (2019)

BK viruria and viremia in children with systemic lupus erythematosus
by: Nirupama Gupta, et al.
Published: (2017)

BK Viremia among Iranian Renal Transplant Candidates
by: Manizheh Jozpanahi, et al.
Published: (2016)

Automated high-throughput quantification of persistent HIV-1 plasma viremia in individuals on ART
by: J. Jacobs, et al.
Published: (2019)

Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
by: Hironori Okada, et al.
Published: (2013)

AAV gene therapy vectors in the TMJ
by: Sabine M. Brouxhon, et al.
Published: (2022)

63 Beach
by: Tiffany Gurprasad
Published: (2012)

Intact proviruses from naive and effector memory T-cells match persistent viremia
by: K. Fisher, et al.
Published: (2019)

BK virus salivary shedding and viremia in renal transplant recipients
by: Dmitry José de Santana Sarmento, et al.
Published: (2019)

Differential viral rebound between lymph node and colon after treatment interruption in SHIV-infected rhesus macaques
by: D.C. Hsu, et al.
Published: (2017)

Elimination of HIV-1/SHIV infected cells by combinations of bispecific HIV x CD3 DART® molecules
by: M. Tuyishime, et al.
Published: (2019)

AAV2 and AAV9 tropism and transgene expression in the mouse eye and major tissues after intravitreal and subretinal delivery
by: Sanna Koponen, et al.
Published: (2023)